Equip DNA Info Lab · Revisió editorial · · 7 min de lectura
Polygenic risk scores (PRS) for non-scientists
Almost every modern genetics report talks about polygenic risk scores, or PRS. The term sounds intimidating but the underlying idea is straightforward. Here's the plain-English version, plus what a PRS can and can't tell you about your health.
One gene, many genes
Some conditions are caused by variants in a single gene. Cystic fibrosis, sickle cell anaemia, Huntington's disease — these are "monogenic" diseases, where variants in one gene are enough to cause the condition. Genetics there is close to binary: you carry the causal variants or you don't.
Most common conditions are different. Type 2 diabetes, heart disease, depression, obesity, most cancers — these are polygenic: many genetic variants, together with environmental influences, each contribute a tiny bit to your overall risk; the NHGRI puts it at hundreds or even thousands of variants per disease. No single one is decisive. The total is what matters.
What a PRS actually computes
A polygenic risk score adds up the contributions of all known risk variants for a given condition, weighted by how strong each one is. Conceptually:
PRS = Σ (your dose of variant i × effect size of variant i)"Dose" is 0, 1 or 2 — how many copies of the risk allele you carry at that position (you have two copies of each chromosome, so the maximum is 2). "Effect size" comes from genome-wide association studies (GWAS) — peer-reviewed papers that measured how much that variant moved disease risk in large groups of people.
How to read your score
Raw PRS numbers are not meaningful on their own. They become meaningful when compared against a population distribution — your score's percentile. A percentile of 80, for example, means your genetic loading for that condition is higher than 80% of people in the reference population.
A report that does show a score may sort it into tiers like these — ours does not, and the section below explains why:
- Low — the lower part of the reference distribution.
- Moderate — the middle of it.
- High — the upper tail. Where each cut-off falls differs from one report to another.
A "high" PRS is not a diagnosis, and there is no general conversion from a percentile to a lifetime risk. What a high score means in absolute terms depends on the disease, on the particular score, on the reference population it was calibrated in and on how common the condition is to begin with; the NHGRI makes the point that two people with the same score can carry different lifetime risks, and that a score on its own supplies neither a baseline nor a time horizon. Only a score validated for one disease in one population can be turned into a risk figure at all. Lifestyle, environment, and other genes you didn't inherit also matter, often more than the polygenic component.
The limitations
There are four big caveats to keep in mind:
- Ancestry bias. About 79% of GWAS participants are of European descent, against 16% of the world's population (Martin et al., Nature Genetics 2019). In that analysis, averaged over 17 traits, scores built from European studies predicted 1.6 times less accurately in Hispanic/Latino participants, 1.7 times in South Asian, 2.5 times in East Asian and 4.9 times in African participants.
- Chip coverage. Microarray-based tests (23andMe, AncestryDNA, MyHeritage) measure a pre-selected set of positions. The 23andMe chip described in a 2017 study carried more than 715,000 SNPs, out of roughly 3 billion nucleotides in the genome — about 0.02%. A variant the chip does not measure is simply absent from your file, so some PRS calculations would benefit from whole-genome sequencing.
- Effect size uncertainty. Each effect size is itself an estimate with a confidence interval. Aggregating many small effects amplifies noise as much as signal. A "high" PRS from one provider and "high" from another may come from different variant lists.
- Population vs individual. Even a perfectly calibrated PRS tells you about the average risk of people like you, not your personal outcome. Two people with identical scores can have radically different lives.
What it's actually useful for
With those caveats, a PRS is a starting point for a conversation, not a verdict. Researchers have proposed using scores to guide earlier screening: a 2018 study built genome-wide scores for coronary artery disease, type 2 diabetes, breast cancer and two other common diseases that picked out a small share of the population at a risk comparable to carrying a rare monogenic mutation, and argued it was time to contemplate them in clinical care. The NHGRI notes that they are not yet routinely used, because there are no guidelines for practice. For most conditions, it's information you can use to inform lifestyle choices: high cardiovascular PRS → take blood pressure more seriously; high lipid PRS → get a fasting lipid panel earlier.
Crucially: a low PRS does not protect you. In a study of 55,685 people, an unfavourable lifestyle — smoking, obesity, little physical activity, a poor diet — was associated with a substantially higher risk of coronary events than a favourable one in every genetic risk category, the lowest included.
What our reports show instead
Our own audit found that most of a category's combined effect came from studies measuring something other than the condition it names — so we withdrew the aggregate number rather than publish one we cannot defend. What a report shows today is every variant of yours that matches the GWAS Catalog (genome-wide significance, p < 5×10⁻⁸), with the trait its study actually measured, the published effect (OR or beta) and a link to the source, plus a plain-language explanation. No aggregate score, no band, no percentile. The methodology page has the full details.
Frequently asked questions
What is a polygenic risk score, in one sentence?▼
It adds up the small contributions of hundreds or thousands of genetic variants for a condition, each weighted by the effect size measured in genome-wide association studies.
Does DNA Info Lab show a PRS or a percentile?▼
No. Our own audit found that most of a category's combined effect came from studies measuring something other than the condition it names, so we withdrew the aggregate number. The report shows each matched variant with the trait its study measured, the published effect and a link to the source.
Is a high PRS a diagnosis?▼
No. There is no general conversion from a percentile to a lifetime risk — that depends on the disease, the particular score and the reference population it was calibrated in. A high score is a starting point for a conversation, not a verdict.
Does a low PRS protect me?▼
No. In a study of 55,685 people, an unfavourable lifestyle (smoking, obesity, little physical activity, a poor diet) was associated with a substantially higher coronary risk in every genetic risk category, the lowest included. Lifestyle, environment and chance matter alongside the polygenic component.
Why do scores work worse for some ancestries?▼
About 79% of GWAS participants are of European descent, against 16% of the world's population, so scores trained on that data predict less well elsewhere: in one 2019 analysis, 1.6 to 4.9 times less accurately in Hispanic/Latino, South Asian, East Asian and African participants.
See which variants your DNA file matches
Upload your raw DNA file. Free summary and clinically-reviewed findings, full report 10 €, private, and no medical advice — just the science, in plain language.
Related articles
Aquest article té finalitats exclusivament educatives i no constitueix consell mèdic, diagnòstic ni tractament. Consulta sempre un professional sanitari per a decisions sobre la teva salut.